Skip to main content

Kardiovaskulär wirksame Medikamente und mechanische Kreislaufunterstützung

  • Chapter
  • 2819 Accesses

Zusammenfassung

Es handelt sich hier um eine Vielzahl von Medikamenten, die unterschiedlichen pharmakologischen Stoffgruppen angehören.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Ausgewählte Literatur

  • Aragon J, Lee MS, Kar S, et al (2005) Percutaneous left ventricular assist device: »TandemHeart« for high-risk coronary intervention. Catheter Cardiovasc Interv 65: 346–352

    Article  PubMed  Google Scholar 

  • De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL; SOAP II Investigators (2010) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362: 779–789

    Article  PubMed  Google Scholar 

  • Erdmann E (2009) (Hrsg.) Klinische Kardiologie – Krankheiten des Herzens, des Kreislaufs und der herznahen Gefäße. 7. Aufl., Springer

    Google Scholar 

  • Ferrari M, Figulla HR (2005) Circulatory assist devices in cardiology. Dtsch Med Wochenschr 130: 652–656

    Article  PubMed  CAS  Google Scholar 

  • Ferrari M, Poerner TC, Brehm BR, et al (2008) First use of a novel plug-and-play percutaneous circulatory assist device for high-risk coronary angioplasty. Acute Card Care 10: 111–115

    Article  PubMed  Google Scholar 

  • Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L; Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360: 196–202

    Google Scholar 

  • Freitas de Souza C, De Souza Brito F, et al. (2010) Percutaneous Mechanical Assistance for the Failing Heart. J Interven Cardiol 23: 195–202

    Article  Google Scholar 

  • Garatti A, Colombo T, Russo C, et al (2006) Left ventricular mechanical support with the Impella Recover left direct microaxial blood pump: A single-center experience. Artif Organs 30: 523–528

    Article  PubMed  Google Scholar 

  • Gopal S, Jayakumar D, Nelson PN (2009) Meta-analysis on the effect of dopexamine on in-hospital mortality. Anaesthesia 64: 589–594

    Article  PubMed  CAS  Google Scholar 

  • Holmes CL, Walley KR (2009) Vasoactive drugs for vasodilatory shock in ICU. Curr Opin Crit Care 15: 398–402

    Article  PubMed  Google Scholar 

  • Kersten JR et al. (2000) Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K (ATP) channels. Anesth Analg 90: 5–11

    Article  PubMed  CAS  Google Scholar 

  • Landoni G, Mizzi A, Biondi-Zoccai G, Bruno G, Bignami E, Corno L, Zambon M, Gerli C, Zangrillo A (2010) Reducing mortality in cardiac surgery with levosimendan: a metaanalysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 24: 51–57

    Article  PubMed  Google Scholar 

  • Landoni G, Mizzi A, Biondi-Zoccai G, Bignami E, Prati P, Ajello V, Marino G, Guarracino F, Zangrillo A (2010) Levosimendan reduces mortality in critically ill patients. A meta-analysis of randomized controlled studies. Minerva Anestesiol. 76: 276–286

    PubMed  CAS  Google Scholar 

  • Lehmann A. et al. (2003) Wirkt Levosimendan bei der operativen Versorgung des akuten Koronarsyndroms inoprotektiv? Anästhesiol Intensivmed Notfallmed Schmerzther 38: 577–582

    Article  PubMed  CAS  Google Scholar 

  • Moiseyev VS et al. (2002) RUSSLAN Study investigators. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute mycardial infarction. A randomized placebocontrolled double blind study (RUSSLAN). Eur Heart J 23: 1422–1432

    Article  PubMed  CAS  Google Scholar 

  • Pavie A, Leger P, Nzomvuama A, et al (1998) Left centrifugal pump cardiac assist with transseptal percutaneous left atrial cannula. Artif Organs 22: 502–507

    Article  PubMed  CAS  Google Scholar 

  • Pulido JN, Park SJ, Rihal CS (2010) Percutaneous Left Ventricular Assist Devices: Clinical Uses, Future Applications, and Anesthetic Considerations. J Cardiothor Vasc Anesth 24: 478–486

    Article  Google Scholar 

  • Rehberg S, Ertmer C, Van Aken H, Lange M, Broking K, Morelli A, Westphal M (2007) Rolle von Levosimendan in der intensivmedizinischen Behandlung des myokardialen Pumpversagens. Anaesthesist 56: 30–43

    Article  PubMed  CAS  Google Scholar 

  • Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper J, Holmes CL, Mehta S, Granton JT, Storms MM, Cook, DJ, Presneill JJ, Ayers D for the VASST Investigators* (2008) Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock. N Engl J Med 358: 877–888

    Article  PubMed  CAS  Google Scholar 

  • Salmenperä M, Eriksson H (2009) Levosimendan in perioperative and critical c are patients. Curr Opin Anaesthesiol 22: 496–501

    Article  PubMed  Google Scholar 

  • Sjauw KD, Engström AE, Vis MM et al. (2009) A systematic review and meta analysis of intra-aortic pump therapy in ST-elevation myocardial infarction: should we change guidelines? Eur Heart J 30: 459–468

    Article  PubMed  Google Scholar 

  • Thiele H, Lauer B, Hambrecht R, et al (2001) Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 104: 2917–2922

    Article  PubMed  CAS  Google Scholar 

  • Thiele H, Smalling RW, Schuler GC (2007) Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 28: 2057–2063

    Article  PubMed  Google Scholar 

  • Trost JC Hillis, LD (2006) Intra-Aortic Balloon Counterpulsation. Am J Cardiol 97: 1391–1398

    Article  PubMed  Google Scholar 

  • Vincent JL, Su F (2008) Physiology and pathophysiology of the vasopressinergic system. Best Pract Res Clin Anaesthesiol 22: 243–252

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fresenius, M., Heck, M. (2011). Kardiovaskulär wirksame Medikamente und mechanische Kreislaufunterstützung. In: Repetitorium Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16879-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-16879-6_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-16878-9

  • Online ISBN: 978-3-642-16879-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics